Role of promoter methylation in regulation of the mammalian heparanase gene

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Oncogene

• Publication date

  2003-10-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.onc.1207056PMID 14586400
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Trans-activation of heparanase promoter by ETS transcription factors

  2003influential reference
• DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells

  2003cited by this paper
• Methylation profile of the MLH1 promoter region and their relationship to colorectal carcinogenesis

  2003cited by this paper
• Effects of 5-aza-2'-deoxycytidine on matrix metalloproteinase expression and pancreatic cancer cell invasiveness.

  2003cited by this paper
• DNA methylation patterns and epigenetic memory.

  2002cited by this paper
• Regulation of DNA Methylation in Human Breast Cancer

  2002influential reference
• 5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy

  2002cited by this paper
• Cloning and Characterization of the Human Heparanase-1 (HPR1) Gene Promoter

  2002influential reference
• DNA methylation in cancer: too much, but also too little

  2002cited by this paper
• MethPrimer: designing primers for methylation PCRs

  2002cited by this paper
• Hypermethylation trigger of the glutathione-S-transferase gene (GSTP1) in prostate cancer cells

  2002cited by this paper
• DNA methylation and gene silencing in cancer: which is the guilty party?

  2002cited by this paper
• Reactivation of a silenced H19 gene in human rhabdomyosarcoma by demethylation of DNA but not by histone hyperacetylation

  2002cited by this paper
• Heparanase expression in human leukemias is restricted to acute myeloid leukemias.

  2002cited by this paper
• Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis.

  2001influential reference
• Heparanase: a key enzyme involved in cell invasion.

  2001cited by this paper
• The microenvironment of the tumour–host interface

  2001cited by this paper
• Heparan sulfate: growth control with a restricted sequence menu.

  2001cited by this paper
• Identification of three non‐VNTR MUC1‐derived HLA‐A*0201‐restricted T‐cell epitopes that induce protective anti‐tumor immunity in HLA‐A2/Kb‐transgenic mice

  2001cited by this paper
• Proteases in invasion: matrix metalloproteinases.

  2001cited by this paper
• Changes in DNA Methylation in Neoplasia: Pathophysiology and Therapeutic Implications

  2001cited by this paper
• Expression Pattern and Secretion of Human and Chicken Heparanase Are Determined by Their Signal Peptide Sequence*

  2001influential reference
• Heparanase expression in primary and metastatic pancreatic cancer.

  2001cited by this paper
• The Role of DNA Methylation in Mammalian Epigenetics

  2001cited by this paper
• ABL1 methylation in Ph-positive ALL is exclusively associated with the P210 form of BCR-ABL

  2001cited by this paper
• Demethylase Activity Is Directed by Histone Acetylation*

  2001cited by this paper
• Molecular diversity of heparan sulfate.

  2001cited by this paper
• The feasibility of PCR-based diagnosis of Prader-Willi and Angelman syndromes using restriction analysis after bisulfite modification of genomic DNA.

  2000cited by this paper
• Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma. Evidence for its role in colonic tumorigenesis.

  2000cited by this paper
• Imprinting: focusing on the center.

  2000cited by this paper
• Heparanase, a potential regulator of cell-matrix interactions.

  2000cited by this paper
• Relationships between chromatin organization and DNA methylation in determining gene expression.

  1999cited by this paper
• ABL1 methylation is a distinct molecular event associated with clonal evolution of chronic myeloid leukemia.

  1999cited by this paper
• Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis

  1999cited by this paper
• DNA methylation represses transcription in vivo

  1999cited by this paper
• Inhibition of heparanase activity and tumor metastasis by laminarin sulfate and synthetic phosphorothioate oligodeoxynucleotides

  1999cited by this paper
• Processing of the Human Heparanase Precursor and Evidence That the Active Enzyme Is a Heterodimer*

  1999cited by this paper
• CpG island methylator phenotypes in aging and cancer.

  1999cited by this paper
• Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer

  1999cited by this paper
• BLAST 2 Sequences, a new tool for comparing protein and nucleotide sequences.

  1999cited by this paper
• Functions of cell surface heparan sulfate proteoglycans.

  1999cited by this paper
• MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex

  1999cited by this paper
• Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation

  1999cited by this paper
• Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasis

  1999cited by this paper
• Human Heparanase

  1999cited by this paper
• CpG methylation, chromatin structure and gene silencing—a three‐way connection

  1998cited by this paper
• Matrix proteoglycans: from molecular design to cellular function.

  1998cited by this paper
• Regulation of the rat thyrotropin receptor gene by the methylation-sensitive transcription factor GA-binding protein.

  1998cited by this paper
• Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal.

  1997cited by this paper
• Methylation of an ETS site in the intron enhancer of the keratin 18 gene participates in tissue-specific repression

  1997cited by this paper
• The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation.

  1996cited by this paper
• The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation.

  1996cited by this paper
• Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

  1996cited by this paper
• CpG islands and genes.

  1995cited by this paper
• A DNA methylation site in the male-specific P450 (Cyp 2d-9) promoter and binding of the heteromeric transcription factor GABP

  1995cited by this paper
• H19 expression and tumorigenicity of choriocarcinoma derived cell lines.

  1995cited by this paper
• High sensitivity mapping of methylated cytosines.

  1994cited by this paper
• Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island.

  1994cited by this paper
• Inhibition of tumor metastasis by heparanase inhibiting species of heparin.

  1994cited by this paper
• Spl elements protect a CpG island from de novo methylation

  1994cited by this paper
• Role of DNA methylation in the regulation of transcription.

  1994cited by this paper
• CpG islands as gene markers in the human genome.

  1992cited by this paper
• Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation.

  1992cited by this paper
• The role of proteoglycans in cell adhesion, migration and proliferation.

  1992cited by this paper
• Heparanases and tumor metastasis

  1988cited by this paper
• CpG-rich islands and the function of DNA methylation

  1986cited by this paper
• Lymphoma cell-mediated degradation of sulfated proteoglycans in the subendothelial extracellular matrix: relationship to tumor cell metastasis.

  1983cited by this paper

• Structure and Function of the Extracellular Matrix in Normal and Pathological Conditions: Looking at the Bicuspid Aortic Valve

  2025cites this paper
• The Pathophysiological Functions of Heparanases: From Evolution, Structural and Tissue‐Specific Perspectives

  2025cites this paper
• Design of Paromomycin and Neomycin as Sulfated and Hydrophobic Glycans to Target Heparanase-Driven Tumor Progression and Metastasis.

  2025cites this paper
• Heparan Sulfate Proteoglycans (HSPGs) and Their Degradation in Health and Disease

  2025cites this paper
• Heparanase—A single protein with multiple enzymatic and nonenzymatic functions

  2023cites this paper
• The Structure and Function of the Glycocalyx and Its Connection With Blood-Brain Barrier

  2021cites this paper
• A guide to the composition and functions of the extracellular matrix

  2021cites this paper
• The Heparanase Regulatory Network in Health and Disease

  2021cites this paper
• What Are the Potential Roles of Nuclear Perlecan and Other Heparan Sulphate Proteoglycans in the Normal and Malignant Phenotype

  2021cites this paper
• The HPSE Gene Insulator—A Novel Regulatory Element That Affects Heparanase Expression, Stem Cell Mobilization, and the Risk of Acute Graft versus Host Disease

  2021cites this paper
• Forty Years of Basic and Translational Heparanase Research

  2020influential citation
• Chemoradiotherapy Increases Intratumor Heterogeneity of HPSE Expression in the Relapsed Glioblastoma Tumors

  2020cites this paper
• Heparanase: Cloning, Function and Regulation.

  2020cites this paper
• Heparanase-The Message Comes in Different Flavors.

  2020cites this paper
• Involvement of Heparanase in Gastric Cancer Progression and Immunotherapy.

  2020cites this paper
• Endothelial glycocalyx as an important factor in composition of blood‐brain barrier

  2020cites this paper
• The heparanase inhibitor PG545 is a potent anti-lymphoma drug: Mode of action.

  2019cites this paper
• Targeting Heparanase in Cancer: Inhibition by Synthetic, Chemically Modified, and Natural Compounds

  2019cites this paper
• Transcriptomic analysis reveals cell apoptotic signature modified by heparanase in melanoma cells

  2019cites this paper
• Sulfotransferase and Heparanase: Remodeling Engines in Promoting Virus Infection and Disease Development

  2018cites this paper
• Heparan Sulfate Proteoglycans in Brain Tumor Development

  2018cites this paper
• S-adenosyl-methionine (SAM) alters the transcriptome and methylome and specifically blocks growth and invasiveness of liver cancer cells

  2017cites this paper
• The Role of the Nucleosome Remodeling Factor NURF in Inhibiting T and Natural Killer Cell Mediated Antitumor Immunity by Suppressing Tumor Antigenicity and Natural Cytotoxicity Receptor Co-ligands

  2017cites this paper
• Methyl donor S-adenosylmethionine (SAM) supplementation attenuates breast cancer growth, invasion, and metastasis in vivo; therapeutic and chemopreventive applications

  2017cites this paper
• DNA Demethylation Agents in Clinical Medicine

  2017cites this paper
• Heparanase: roles in cell survival, extracellular matrix remodelling and the development of kidney disease

  2017cites this paper
• Heparanase 1 involvement in prostate physiopathology

  2017cites this paper
• Heparanase: From basic research to therapeutic applications in cancer and inflammation.

  2016cites this paper
• Newly uncovered novel properties of heparanase in the heart and pancreas

  2016cites this paper
• Heparanase-neutralizing antibodies attenuate lymphoma tumor growth and metastasis

  2016cites this paper
• DNA-hypomethylating agent, 5'-azacytidine, induces cyclooxygenase-2 expression via the PI3-kinase/Akt and extracellular signal-regulated kinase-1/2 pathways in human HT1080 fibrosarcoma cells.

  2015cites this paper
• DNA demethylation and invasive cancer: implications for therapeutics

  2015cites this paper
• The increasing roles of epigenetics in breast cancer: Implications for pathogenicity, biomarkers, prevention and treatment

  2015cites this paper
• The regulations of miR-30c-3-3p and its antitumor mechanism in ovarian cancer

  2015cites this paper
• Molecular Epigenetics in the Management of Ovarian Cancer: Are We Investigating a Rational Clinical Promise?

  2014cites this paper
• DNA Methylation of Heparanase Promoter Influences Its Expression and Associated with the Progression of Human Breast Cancer

  2014cites this paper
• Synergistic effects of combined DNA methyltransferase inhibition and MBD2 depletion on breast cancer cells; MBD2 depletion blocks 5-aza-2'-deoxycytidine-triggered invasiveness.

  2014cites this paper
• Heparanase as a target in cancer therapy.

  2014cites this paper
• Synergistic anti-breast cancer effect of a combined treatment with the methyl donor S-adenosyl methionine and the DNA methylation inhibitor 5-aza-2'-deoxycytidine.

  2014cites this paper
• Fumonisin B1 induces global DNA hypomethylation in HepG2 cells - An alternative mechanism of action.

  2014cites this paper
• Versatile role of heparanase in inflammation.

  2013cites this paper
• Normal colon tissue and colon carcinoma show no difference in heparanase promoter methylation.

  2013cites this paper
• Heparanase in inflammation and inflammation‐associated cancer

  2013cites this paper
• Heparanase Downmodulation in the Process of Epithelial-to-Mesenchymal Transition of Mouse Mammary Epithelial Cells

  2013cites this paper
• DNA methylation signatures for breast cancer classification and prognosis

  2012cites this paper
• Heparanase enzyme in chronic inflammatory bowel disease and colon cancer

  2012cites this paper
• De novo DNA methyltransferases: oncogenes, tumor suppressors, or both?

  2012cites this paper
• Inhibition of matrix metalloproteinase-2 by halofuginone is mediated by the Egr1 transcription factor

  2012cites this paper
• Defining the Structural Cues within Heparan Sulfate that Direct Heparanase Cleavage

  2012cites this paper
• Breast cancer classification, staging and prognosis: the importance of DNA methylation signatures

  2012cites this paper
• Heparan sulfate D-glucosaminyl 3-O-sulfotransferase-3B1, a novel epithelial-mesenchymal transition inducer in pancreatic cancer

  2011cites this paper
• Effects of specific DNMT gene depletion on cancer cell transformation and breast cancer cell invasion; toward selective DNMT inhibitors.

  2011cites this paper
• Endothelial heparanase regulation of cardiac metabolism

  2011cites this paper
• Definition of the landscape of promoter DNA hypomethylation in liver cancer.

  2011cites this paper
• The implications of DNA methylation for toxicology: toward toxicomethylomics, the toxicology of DNA methylation.

  2011cites this paper
• Prostaglandin E2 promotes intestinal tumor growth via DNA methylation

  2011cites this paper
• The heparanase system and tumor metastasis: is heparanase the seed and soil?

  2011cites this paper
• Neonatal exposure to high doses of 17β-estradiol results in inhibition of heparanase-1 expression in the adult prostate

  2011cites this paper
• Post‐transcriptional regulation of heparanase gene expression by a 3’ AU‐rich element

  2010cites this paper
• A novel human heparanase splice variant, T5, endowed with protumorigenic characteristics

  2010cites this paper
• Preferential up‐regulation of heparanase and cyclooxygenase‐2 in carcinogenesis of Barrett’s oesophagus and intestinal‐type gastric carcinoma

  2010cites this paper
• Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis

  2010cites this paper
• Development of Aptamers as Diagnostic and Therapeutic Agents

  2010cites this paper
• Heparanase drives the aggressive myeloma phenotype: Preclinical development of a heparanase inhibitor for the treatment of multiple myeloma

  2010cites this paper
• DNA methylation and demethylation probed by small molecules.

  2010cites this paper
• Dynamic Histone Variant Exchange Accompanies Gene Induction in T Cells

  2009cites this paper
• Newly Generated Heparanase Knock-Out Mice Unravel Co-Regulation of Heparanase and Matrix Metalloproteinases

  2009cites this paper
• Epigenetics, DNA methylation, and chromatin modifying drugs.

  2009cites this paper
• Quantitative Analysis of Heparanase Gene Expression in Normal Cervical, Cervical Intraepithelial Neoplastic, and Cervical Carcinoma Tissues

  2008cites this paper
• Pharmacological inhibition of DNA methylation induces proinvasive and prometastatic genes in vitro and in vivo.

  2008cites this paper
• Requirement of the conserved, hydrophobic C-terminus region for the activation of heparanase.

  2008cites this paper
• DNA demethylation and cancer metastasis: therapeutic implications

  2008cites this paper
• Epigenetic Regulation of HYAL-1 Hyaluronidase Expression

  2008cites this paper
• Heparanase expression in B16 melanoma cells and peripheral blood neutrophils before and after extravasation detected by novel anti-mouse heparanase monoclonal antibodies.

  2008cites this paper
• Molecular and Cellular Aspects of Heparanase

  2008cites this paper
• The role of dna hypermethylation and demethylation in cancer and cancer therapy

  2008cites this paper
• Two Heparanase Splicing Variants with Distinct Properties Are Necessary in Early Xenopus Development*

  2008cites this paper
• Heparanase involvement in physiology and disease

  2008cites this paper
• A phase I pharmacological and biological study of PI-88 and docetaxel in patients with advanced malignancies

  2008cites this paper
• Involvement of disulfide bond formation in the activation of heparanase.

  2007cites this paper
• Epigenetic regulation of bone morphogenetic protein-6 gene expression in breast cancer cells.

  2007cites this paper
• Role of heparanase and heparanase-degraded heparan sulfate in brain-metastatic melanoma

  2007cites this paper
• Heparanase: a target for drug discovery in cancer and inflammation

  2007cites this paper
• Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate.

  2007cites this paper
• Heparanase expression in circulating lymphocytes of breast cancer patients depends on the presence of the primary tumor and/or systemic metastasis.

  2007cites this paper
• Regulation of mouse Heparanase gene expression in T lymphocytes and tumor cells

  2007cites this paper
• Mammalian heparanase: what is the message?

  2007cites this paper
• Spatial and temporal heparanase expression in colon mucosa throughout the adenoma-carcinoma sequence

  2006cites this paper
• Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective.

  2006cites this paper
• Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis.

  2006influential citation
• Tumor suppressor p53 regulates heparanase gene expression

  2006cites this paper
• Targeting DNA methylation in cancer.

  2006cites this paper
• Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation.

  2006cites this paper
• Knowledge of epigenetic influence for prostate cancer therapy.

  2006cites this paper
• Development of heparanase inhibitors for anti-cancer therapy.

  2006cites this paper
• DNA Methylation and Demethylation as Targets for Anticancer Therapy

  2005cites this paper
• Heparan Sulfate Degradation by Heparanases

  2005cites this paper
• Promoter CpG hypomethylation and transcription factor EGR1 hyperactivate heparanase expression in bladder cancer

  2005cites this paper
• Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer.

  2005cites this paper
• Therapeutic implications of DNA methylation.

  2005cites this paper